BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3297202)

  • 1. Clinical experience with transfusion of leukocyte-poor platelet concentrates prepared by filtration with prostacyclin.
    van Prooijen HC; Riemens TI; Akkerman JW
    Blood; 1987 Jul; 70(1):243-6. PubMed ID: 3297202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of leukocyte-poor platelet concentrates for transfusion by filtration through a new cellulose acetate filter.
    Koerner K
    Haematologia (Budap); 1989; 22(3):181-8. PubMed ID: 2583598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filtration. A method to prepare white cell-poor platelet concentrates with optimal preservation of platelet viability.
    van Marwijk Kooy M; van Prooijen HC; Borghuis L; Moes M; Akkerman JW
    Transfusion; 1990 Jan; 30(1):34-8. PubMed ID: 2296787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of white cells from platelet concentrates with a new adsorption filter.
    Kickler TS; Bell W; Drew H; Pall D
    Transfusion; 1989 Jun; 29(5):411-4. PubMed ID: 2734820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
    van Marwijk Kooy M; van Prooijen HC; Moes M; Bosma-Stants I; Akkerman JW
    Blood; 1991 Jan; 77(1):201-5. PubMed ID: 1984797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte-poor platelet concentrates at the bedside by filtration through Sepacell-PL.
    Miyamoto M; Sasakawa S; Ishikawa Y; Ogawa A; Nishimura T; Kuroda T
    Vox Sang; 1989; 57(3):164-7. PubMed ID: 2617950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group
    N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White cell depletion of single-donor platelet preparations by a new adsorption filter.
    Böck M; Heim MU; Weindler R; Bilas A; Greither L; Salat C; Mempel W
    Transfusion; 1991 May; 31(4):333-4. PubMed ID: 2020997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration.
    Andreu G; Dewailly J; Leberre C; Quarre MC; Bidet ML; Tardivel R; Devers L; Lam Y; Soreau E; Boccaccio C
    Blood; 1988 Sep; 72(3):964-9. PubMed ID: 3416079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of leukocyte-free platelets for transfusion by filtration through cotton wool.
    Sirchia G; Parravicini A; Rebulla P; Bertolini F; Morelati F; Marconi M
    Vox Sang; 1983; 44(2):115-20. PubMed ID: 6829183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Production of leukocyte-poor thrombocyte concentrates: results with a new kind of filter system].
    Böck M; Salat C; Greither L; Heim MU; Weindler R; Bilas A; Mempel W
    Beitr Infusionsther; 1990; 26():103-5. PubMed ID: 1703804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion experience with platelet concentrates stored for 24 to 72 hours at 22 degrees C. Importance of storage time.
    Lazarus HM; Herzig RH; Warm SE; Fishman DJ
    Transfusion; 1982; 22(1):39-43. PubMed ID: 7064205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
    Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G
    Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
    Handa M; Ikeda Y; Kurata Y; Tsubaki K; Horiuchi A; Furihata K; Kimura Y; Toyama K; Takamoto S; Tsukimoto I
    Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukopoor platelet concentrates: a direct comparison of three blood filters.
    Medeiros LJ; Dzik WH
    Ann Clin Lab Sci; 1985; 15(3):237-40. PubMed ID: 3994293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates.
    Menitove JE; Frenzke M; Aster RH
    Transfusion; 1984; 24(6):528-31. PubMed ID: 6390814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of leukocyte-poor platelets by filtration.
    Sniecinski I; Jean JS; Nowicki B
    J Clin Apher; 1989; 5(1):7-11. PubMed ID: 2777739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of posttransfusion recoveries achieved with either fresh or stored platelet concentrates.
    Peter-Salonen K; Bucher U; Nydegger UE
    Blut; 1987 Apr; 54(4):207-12. PubMed ID: 3828538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion results of filtered and subsequently stored random platelet suspensions prepared from buffy coats.
    Novotny VM; van Doorn R; Rozier Y; D'Amaro J; Harvey MS; Brand A
    Vox Sang; 1992; 63(1):23-30. PubMed ID: 1413660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.